Compare AFLAC Incorporated (AFL) vs Docusign Inc (DOCU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs Docusign Inc — how do they compare? AFLAC Incorporated trades at $121.27 (market cap $61.84B), while Docusign Inc trades at $47.19 (market cap $9.02B). The key difference: AFLAC Incorporated is far larger — about 6.9× Docusign Inc's market cap, and AFLAC Incorporated pays a 2.01% dividend while Docusign Inc pays none. Which is the better fit depends on your goals.
| AFL | DOCU | |
|---|---|---|
Market Cap | $61.84B | $9.02B |
Sector | Financials | Technology |
52-Week High | $121.49 | $85.01 |
52-Week Low | $98.09 | $41.75 |
Enterprise Value | $70.50B | $8.39B |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
DOCU trades at $47.23, up 3.19% with a bullish technical signal. Recent earnings consistently beat expectations, with Q1 2026 EPS of $1.09 exceeding estimates. Revenue growth remains steady, reaching $2.98B in 2025, while profitability improved significantly with a net income margin of 35.87%. The company's partnerships with Perplexity and Slack highlight ongoing innovation in agreement management workflows, supporting future growth prospects amid positive analyst sentiment.
The outlook for DOCU is cautiously optimistic, with a consensus price target of $55.40 suggesting 17% upside. Key opportunities include expanding AI integration and enterprise adoption, but risks involve competitive pressures and reliance on subscription revenue stability. Valuation metrics like a P/E of 30.45 require sustained earnings growth to justify current levels, making execution critical for shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →
